Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00880451 · ClinicalTrials.gov registry record

Development and Decline of Brain and Cognition Through the Life Span

A clinical trial of Alzheimers Disease, sponsored by National Institute of Mental Health (NIMH).

Completed
Registry status
1
Study location

NCT00880451: Completed study of Alzheimers Disease, sponsored by National Institute of Mental Health (NIMH).

NCT00880451 is a study of Alzheimers Disease that has completed, run by National Institute of Mental Health (NIMH). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00880451, a study of Alzheimers Disease, has completed, sponsored by National Institute of Mental Health (NIMH).

COMPLETED
Registry status
1
Study location

Study Summary

The protocol objectives are to enable prospective IRB review of research using human MRI scans and data collected under other branch protocols or extramural sources. By combining data from multiple sources the investigators will be able to conduct analyses that require large numbers of observations that exceed the numbers collected in any single study. They will also be able to stratify and subgroup the combined samples in different ways to permit analyses that would otherwise not be possible. The study population consists of normal individuals and clinical groups of all ages. Clinical groups will be added by amendment including patients suffering from schizophrenia, ADHD, autism, Klinefelter's disease, and Alzheimer's disease. The study design consists of 1) automated segmentation of MRI brain scans to obtain regional measurements of cortical thickness and volumetric measurements of brain structures including basal ganglia, 2) manual segmentation of brain structures and brain anomalies not amenable to automated segmentation such as Virchow-Robbins spaces, 3) correlation analyses between MRI brain measurements and available demographic (e.g. gender) and physiological (e.g. BMI) data, statistical analysis of group differences where the groups are defined by diagnosis, age, gender or by other potentially useful classification. Since all data were collected under other protocols there are no additional risks or benefits associated with this protocol. This protocol combines MRI data from disparate sources and can provide important information regarding factors that may affect the comparability of MRI scans obtained from different sites using various types of MRI scanners and pulse sequences to generate MRI images. It will also enable the analysis of specific subgroups with sufficient numbers of observations for meaningful statistics.

Conditions Studied

Study Locations (1)

Maryland

  • National Institute of Mental Health (NIMH), 9000 Rockville Pike - Bethesda

Trial Details

FieldValue
Start Date 2009-03

What the finished NCT00880451 record still lists

NCT00880451 is an observational study that tracks outcomes without assigning an intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 1 condition, with Alzheimers Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00880451 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00880451 about?

NCT00880451 is a clinical study titled "Development and Decline of Brain and Cognition Through the Life Span". The protocol objectives are to enable prospective IRB review of research using human MRI scans and data collected under other branch protocols or extramural sources. By combining data from multiple sources the investigators will be able to conduct analyses that require large numbers of observations ...

What is the current status of trial NCT00880451?

This trial is currently completed. The study started on 2009-03.

What conditions does trial NCT00880451 study?

This clinical trial studies the following conditions: Alzheimers Disease.

Who is sponsoring clinical trial NCT00880451?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00880451 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00880451, the US trial registry maintained by the National Library of Medicine. NCT00880451 (unsized enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.